ReviewCancers2021

Prostaglandin E2 Receptor 4 (EP4) as a Therapeutic Target to Impede Breast Cancer-Associated Angiogenesis and Lymphangiogenesis.

Guillermo Antonio De Paz Linares et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.